1. Profile
  2. Michael W. Naylor

Michael W. Naylor MD

Michael W. Naylor
  • Professor of Clinical Psychiatry
  • Director, Behavioral Health and Welfare Program
  • Director, Comprehensive Assessment and Response Training System
  • Director, Clinical Services in Psychopharmacology
Contact Information
  • mnaylor [at]
  • (312) 413-4567
  • Institute for Juvenile Research (IJR)
    1747 W. Roosevelt Rd.
    Chicago IL 60612

Dr. Naylor is a Professor of Psychiatry at the University of Illinois Chicago School of Medicine. He is the Director of the Behavioral Health and Welfare Program, a program formed by contract between the Department of Children and Family Services (DCFS) and UIC to address the mental health needs of the most severely disturbed state wards. In addition, he directs the UIC Clinical Services in Psychopharmacology Program and consults with the DCFS Psychotropic Medication Consent Line regarding psychotropic medication consents for youth in state custody. He is board certified in child and adolescent psychiatry, general psychiatry and sleep disorders medicine and is an expert in child and adolescent mood disorders and psychopharmacology. He has published more than 100 peer reviewed manuscripts, abstracts and book chapters and has presented his work at national meetings. Dr. Naylor received the 2008 Norbert and Charlotte Rieger Service Program Award for Excellence as the Director of the Behavioral Health and Welfare Program. Dr. Naylor earned his medical degree from the University of North Dakota School of Medicine. He completed his general psychiatry residency, his child and adolescent psychiatry fellowship, and his sleep disorders fellowship at the University of Michigan School of Medicine.

  • psychiatry


  • Utilization of Psychotropic Medications by Youth in State Custody

  • Naylor MW, Greden JF, Alessi NE: Plasma dexamethasone levels in children given the dexamethasone suppression test. Biological Psychiatry,27:592-600, 1990.

    Naylor MW, Shain BN, Shipley JE: REM latency in psychotically depressed adolescents. Biological Psychiatry, 28:161-164, 1990.

    Venkataraman S, Naylor MW, King CA: Fluoxetine induced mania in depressed adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 31:276-281, 1992.

    Naylor MW, King CA, Lindsay KA, Evans T, Armelagos J, Shain BN, Greden JF: The effects of sleep deprivation on mood in depressed adolescents and psychiatric controls.Journal of the American Academy of Child and Adolescent Psychiatry,32:753-759, 1993.

    Naylor MW, Staskowski M, Kenney MC, King CA: Language disorders and learning disabilities in school refusing adolescents. Journal of the American Academy of Child and Adolescent Psychiatry), 33:1331-133, 1994.

    Kaminski KM, Naylor MW, Cheryl CA, Ghaziuddin N: Reactive mood and atypical depression in psychiatrically hospitalized adolescents. Depression,3:176-181, 1995.

    Ghaziuddin N, King C, Ghaziuddin M, Naylor M, Chaudry N, Giordani B, DeQuardo J, Tandon R, Greden JF: Electroconvulsive treatment in adolescents with pharmacotherapy refractory depression: A prospective study. Journal of Child and Adolescent Psychopharmacology, 6:259-271, 1996.

    Naylor MW, Anderson TR, Morris, A: Child psychiatry and child welfare: A collaboration for change. Residential Treatment for Children and Youth, 21:33-50, 2003.
    Pavuluri MN, Henry D, Naylor M, Carbray J, Sampson G, Janicak PG: A pharmacotherapy algorithm for stabilization and maintenance of pediatric bipolar disorder. Journal of American Academy of Child and Adolescent Psychiatry, 43(7):859-867, 2004.

    Pavuluri MN, Henry DB, Carbray JA, Naylor MW, Janicak PG: Divalproex sodium for pediatric mixed mania: a 6-month prospective trialBipolar Disorders, 7(3):266-73, 2005.

    Pavuluri MN, Birmaher B, Naylor MWPediatric bipolar disorder: A review of the past 10 yearsJournal of the American Academy of Child and Adolescent Psychiatry. 44(9):846-71, 2005.

    Kratochvil C J, Vitiello B, Brent D, Bostic JQ, Naylor MWSelecting an antidepressant for the treatment of pediatric depression. Journal of the American Academy of Child & Adolescent Psychiatry, 45:371-373, 2006.

    Pavuluri MN, Henry DB, Carbray JA, Sampson GA, Naylor MW, Janicak PG: A one-year open-label trial of risperidone augmentation in lithium nonresponder youth with preschool-onset bipolar disorderJournal of Child & Adolescent Psychopharmacology.16(3):336-50, 2006.

    Naylor MW, Davidson C, Ortega-Piron DJ, Bass A, Gutierrez A, Hall A: Psychotropic medication management for youths in state care: Pharmacoepidemiology and policy considerationsChild Welfare,86(5):175 - 192, 2007.

    Slade M, et al.: Best practices for the treatment of patients with mental and substance use illnesses in the emergency Department.Disease-a-Month, 55(11/12):529-580, 2007.